1. Home
  2. WNC vs KMDA Comparison

WNC vs KMDA Comparison

Compare WNC & KMDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

WNC

Wabash National Corporation

N/A

Current Price

$11.95

Market Cap

511.7M

Sector

Industrials

ML Signal

N/A

Logo Kamada Ltd.

KMDA

Kamada Ltd.

N/A

Current Price

$7.95

Market Cap

460.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
WNC
KMDA
Founded
1985
1990
Country
United States
Israel
Employees
N/A
N/A
Industry
Construction/Ag Equipment/Trucks
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
511.7M
460.3M
IPO Year
2009
2013

Fundamental Metrics

Financial Performance
Metric
WNC
KMDA
Price
$11.95
$7.95
Analyst Decision
Hold
Strong Buy
Analyst Count
1
2
Target Price
$11.00
$14.00
AVG Volume (30 Days)
1.0M
106.3K
Earning Date
05-01-2026
05-13-2026
Dividend Yield
3.84%
3.08%
EPS Growth
179.22
N/A
EPS
N/A
N/A
Revenue
$2,027,489,000.00
N/A
Revenue This Year
$10.65
$13.94
Revenue Next Year
$14.06
$9.84
P/E Ratio
N/A
$24.59
Revenue Growth
8.81
N/A
52 Week Low
$6.63
$6.50
52 Week High
$14.32
$9.35

Technical Indicators

Market Signals
Indicator
WNC
KMDA
Relative Strength Index (RSI) 44.34 64.30
Support Level $11.73 $6.94
Resistance Level $13.02 $8.05
Average True Range (ATR) 0.53 0.21
MACD -0.11 0.09
Stochastic Oscillator 15.68 91.59

Price Performance

Historical Comparison
WNC
KMDA

About WNC Wabash National Corporation

Wabash National Corp operates as the innovation leader of connected solutions for the transportation, logistics, and distribution industries. The Company manages its business in two operating and reportable segments: Transportation Solutions and Parts & Services. It designs and manufactures products including dry freight and refrigerated trailers, platform trailers, tank trailers, dry and refrigerated truck bodies, structural composite panels and products, trailer aerodynamic solutions, and specialty food-grade processing equipment.

About KMDA Kamada Ltd.

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.

Share on Social Networks: